NIH Director Sides With Venture Capital-Backed Firms On SBIR Awards
This article was originally published in The Gray Sheet
Executive Summary
Biotech industry representatives cited a recent letter by NIH Director Elias Zerhouni during a July 27 congressional hearing in which they pressed lawmakers to repeal restrictions that disqualify some small businesses from competing for government research grants